Between all the different acids, hydrators, peptides, and other clinical ingredient names that sound like something you ...

An Ocular Therapeutix drug developed for the wet form of age-related macular degeneration was better at helping patients maintain vision compared to a blockbuster Regeneron Pharmaceuticals drug that ...

The U.S. Space Force has awarded SpaceX nine task orders worth $739 million combined to provide Lane 1 launch services under the National Security Space Launch, or NSSL, program’s third phase. The ...

If you’re running the iOS 26.3 beta, Apple has just released a new security update you can install. But there’s a catch: rather than including fixes, the update is simply testing out a new system.

Blue Origin’s New Glenn rocket at liftoff during the NG-2 mission on Nov. 13. Credit: Blue Origin The U.S. Space Force is now taking proposals from new launch providers with rockets ready to fly by ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

ATLANTA — Eli Lilly’s investigational oral GLP-1 drug orforglipron produced significant weight loss, A1c reduction, and cardiovascular risk factor improvements in the company’s Phase 3 ATTAIN-2 trial ...

IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...

VaporTheGamer reacts to tricky mod phase 3 is literal madness! [part 1] with fun commentary, unique insights, and FNAF or FNF fan excitement. VIDEO: Hay fraud hits local farms Flooded outfield results ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...

(RTTNews) - Eli Lilly and Co. (LLY) announced Wednesday positive topline results from ACHIEVE-3, an open-label randomized Phase 3 clinical trial evaluating the safety and efficacy of orforglipron ...